{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:14:26Z","timestamp":1758708866583},"reference-count":52,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.vaccine.2010.04.071","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T08:55:38Z","timestamp":1273222538000},"page":"4644-4652","source":"Crossref","is-referenced-by-count":22,"title":["Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii"],"prefix":"10.1016","volume":"28","author":[{"given":"Cristina T.","family":"Stoyanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia B.","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Deroubaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Barba-Spaeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth S.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (5192)","key":"10.1016\/j.vaccine.2010.04.071_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/222488a0","article-title":"Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites","volume":"222","author":"Nussenzweig","year":"1969","journal-title":"Nature"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.04.071_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4269\/ajtmh.1975.24.397","article-title":"Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites","volume":"24","author":"Clyde","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.04.071_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0065-2776(08)60695-1","article-title":"Rationale for the development of an engineered sporozoite malaria vaccine","volume":"45","author":"Nussenzweig","year":"1989","journal-title":"Adv Immunol"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2010.04.071_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cell.2007.09.013","article-title":"Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite","volume":"131","author":"Singh","year":"2007","journal-title":"Cell"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.04.071_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.177.5.1287","article-title":"Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes","volume":"177","author":"Frevert","year":"1993","journal-title":"J Exp Med"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.04.071_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group","volume":"336","author":"Stoute","year":"1997","journal-title":"N Engl J Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.04.071_bib7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/515657","article-title":"Long-term efficacy and immune responses following immunization with the RTS. S malaria vaccine","volume":"178","author":"Stoute","year":"1998","journal-title":"J Infect Dis"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2010.04.071_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"issue":"November (9598)","key":"10.1016\/j.vaccine.2010.04.071_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(07)61542-6","article-title":"Safety of the RTS, S\/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I\/IIb trial","volume":"370","author":"Aponte","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.04.071_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.04.071_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11908-996-0005-9","article-title":"Current Assessment of Yellow Fever and Yellow Fever Vaccine","volume":"6","author":"Lefeuvre","year":"2004","journal-title":"Curr Infect Dis Rep"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.04.071_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2010.04.071_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"issue":"January (Pt 1)","key":"10.1016\/j.vaccine.2010.04.071_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J Gen Virol"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2010.04.071_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vac"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2010.04.071_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/hv.1.3.1797","article-title":"Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates","volume":"1","author":"Dean","year":"2005","journal-title":"Hum Vac"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2010.04.071_bib17","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2010.04.071_bib18","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.04.071_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4269\/ajtmh.2005.72.74","article-title":"Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells","volume":"72","author":"Brandler","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.04.071_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J Exp Med"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2010.04.071_bib21","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation","volume":"1","author":"Rice","year":"1989","journal-title":"New Biol"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2010.04.071_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-2836(87)90455-4","article-title":"Conserved elements in the 3\u2032 untranslated region of flavivirus RNAs and potential cyclization sequences","volume":"198","author":"Hahn","year":"1987","journal-title":"J Mol Biol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.04.071_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.20051639","article-title":"Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses","volume":"203","author":"Boscardin","year":"2006","journal-title":"J Exp Med"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2010.04.071_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.194.2.173","article-title":"Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages","volume":"194","author":"Sano","year":"2001","journal-title":"J Exp Med"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2010.04.071_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.04.071_bib26","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"issue":"October (Pt 10)","key":"10.1016\/j.vaccine.2010.04.071_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1099\/0022-1317-65-10-1637","article-title":"Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies","volume":"65","author":"Schlesinger","year":"1984","journal-title":"J Gen Virol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2010.04.071_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0042-6822(89)90045-7","article-title":"Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis","volume":"169","author":"Chambers","year":"1989","journal-title":"Virology"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2010.04.071_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.04.071_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-3024.2008.01077.x","article-title":"Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues","volume":"31","author":"Vaughan","year":"2009","journal-title":"Parasite Immunol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2010.04.071_bib31","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.4049\/jimmunol.159.7.3424","article-title":"Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides","volume":"159","author":"Franke","year":"1997","journal-title":"J Immunol"},{"issue":"August (1\u20133)","key":"10.1016\/j.vaccine.2010.04.071_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-2478(90)90086-6","article-title":"Isolation and characterization of protective cytolytic T cells in a rodent malaria model system","volume":"25","author":"Romero","year":"1990","journal-title":"Immunol Lett"},{"issue":"March (7)","key":"10.1016\/j.vaccine.2010.04.071_bib33","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/S0021-9258(18)61449-8","article-title":"Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines","volume":"262","author":"Lal","year":"1987","journal-title":"J Biol Chem"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.04.071_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.171.3.763","article-title":"Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes","volume":"171","author":"Weiss","year":"1990","journal-title":"J Exp Med"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.04.071_bib35","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/JVI.77.2.1644-1648.2003","article-title":"Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins","volume":"77","author":"Molenkamp","year":"2003","journal-title":"J Virol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2010.04.071_bib36","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"Khromykh","year":"2001","journal-title":"J Virol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.04.071_bib37","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"Tscherne","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.071_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"Bonaldo","year":"2007","journal-title":"Virol J"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.04.071_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/eji.1830200604","article-title":"Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii","volume":"20","author":"Grillot","year":"1990","journal-title":"Eur J Immunol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2010.04.071_bib40","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1073\/pnas.88.18.7963","article-title":"In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide","volume":"88","author":"Renia","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (1\u20133)","key":"10.1016\/j.vaccine.2010.04.071_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-2478(90)90092-5","article-title":"Peptide-primed CD4+ cells and malaria sporozoites","volume":"25","author":"Del Giudice","year":"1990","journal-title":"Immunol Lett"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2010.04.071_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4049\/jimmunol.107.1.236","article-title":"Role of macrophages and antibody in resistance of mice against yellow fever virus","volume":"107","author":"Zisman","year":"1971","journal-title":"J Immunol"},{"issue":"December (6149)","key":"10.1016\/j.vaccine.2010.04.071_bib43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/330664a0","article-title":"Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites","volume":"330","author":"Schofield","year":"1987","journal-title":"Nature"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.04.071_bib44","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1073\/pnas.88.8.3300","article-title":"Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein","volume":"88","author":"Malik","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (6240)","key":"10.1016\/j.vaccine.2010.04.071_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/341323a0","article-title":"Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria","volume":"341","author":"Romero","year":"1989","journal-title":"Nature"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.04.071_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.85.2.573","article-title":"CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.04.071_bib47","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.150.4.1471","article-title":"Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages","volume":"150","author":"Renia","year":"1993","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.04.071_bib48","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/IAI.01420-07","article-title":"Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy","volume":"76","author":"Othoro","year":"2008","journal-title":"Infect Immun"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2010.04.071_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/339408","article-title":"Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria","volume":"185","author":"Dodoo","year":"2002","journal-title":"J Infect Dis"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2010.04.071_bib50","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1086\/592971","article-title":"Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children","volume":"47","author":"D\u2019Ombrain","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"April (V)","key":"10.1016\/j.vaccine.2010.04.071_bib51","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/314689","article-title":"Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children","volume":"179","author":"Luty","year":"1999","journal-title":"J Infect Dis"},{"issue":"July (5)","key":"10.1016\/j.vaccine.2010.04.071_bib52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"Roestenberg","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T02:35:35Z","timestamp":1685586935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10006079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":52,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0264410X10006079"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}